Shinoda et al., 1987 - Google Patents
Inhibitory effect of capsular antigen of Vibrio vulnificus on bactericidal activity of human serumShinoda et al., 1987
View PDF- Document ID
- 15100388459809299458
- Author
- Shinoda S
- Kobayashi M
- Yamada H
- Yoshida S
- Ogawa M
- Mizuguchi Y
- Publication year
- Publication venue
- Microbiology and immunology
External Links
Snippet
on Bactericidal Activity of Human Serum Vibrio vulnificus, a slightly halophilic marine bacterium,
has been recently recognized Page 1 Microbiol. Immunol. Vol. 31 (5), 393-401, 1987 Inhibitory
Effect of Capsular Antigen of •ôNH•ôVibrio vulnificus•ôNS•ô on Bactericidal Activity of Human …
- 241000607265 Vibrio vulnificus 0 title abstract description 25
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Micro-organisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/04—Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stoenner et al. | Antigenic variation of Borrelia hermsii. | |
| Cavanaugh et al. | The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague | |
| Williams et al. | Immunological and biological characterization of Coxiella burnetii, phases I and II, separated from host components | |
| Eisenstein | Evidence for O antigens as the antigenic determinants in" ribosomal" vaccines prepared from Salmonella | |
| Gemski Jr et al. | Virulence of Shigella flexneri hybrids expressing Escherichia coli somatic antigens | |
| Vaara et al. | An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action. | |
| Shinoda et al. | Inhibitory effect of capsular antigen of Vibrio vulnificus on bactericidal activity of human serum | |
| Thomas et al. | Studies on primary atypical pneumonia. II. Observations concerning the relationship of a non-hemolytic streptococcus to the disease | |
| Namioka | Chapter X Pasteurella multocida---Biochemical Characteristics and Serotypes | |
| Sakulramrung et al. | Cross-reactive immunoprotective antibodies to Escherichia coli 0111 rough mutant J5 | |
| Kreger et al. | Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera | |
| Guirguis et al. | Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies. | |
| Mulholland et al. | Quantitative studies of febrile tolerance and levels of specific antibody evoked by bacterial endotoxin | |
| Young et al. | Agar-gel precipitating antibody in Pseudomonas aeruginosa infections | |
| Lancefield | Loss of the properties of hemolysin and pigment formation without change in immunological specificity in a strain of Streptococcus haemolyticus | |
| Bokkenheuser | Vibrio fetus infection in man: a serological test | |
| Beachey et al. | Type-specific inhibition of preopsonization versus immunoprecipitation by streptococcal M proteins | |
| Domingue et al. | Opsonizing and bactericidal activity of antibodies against common antigen of Enterobacteriaceae | |
| Wiley et al. | The ability of group A streptococci killed by heat or mercury arc irradiation to resist ingestion by phagocytes | |
| Gilsdorf et al. | Susceptibility of phenotypic variants of Haemophilus influenzae type b to serum bactericidal activity: relation to surface lipopolysaccharide | |
| Pitt et al. | 3 Serological Typing of Serratia marcescens | |
| Zweerink et al. | X-linked immunodeficient mice as a model for testing the protective efficacy of monoclonal antibodies against Pseudomonas aeruginosa | |
| Neter et al. | Study on antibodies against enteric pathogens in human gamma globulin | |
| Fierer et al. | Release of 51Cr-endotoxin from bacteria as an assay of serum bactericidal activity | |
| Scales et al. | Development and passive transfer of immunity to gonococcal infection in guinea pigs |